Aktieinformation Sequana Medical | Filter Basic-Info
Aktie: Sequana Medical (Bel lokal)
| Senast pris | 1.10 | Maxpris | 3.87 |
| Minimumpris | 0.58 | 1 års avkastning | -64.05 |
| Avg. Target | 5.00 | Genomsnittlig priskurs | 354.55 % |
| Sektor | Health Care | Undersektor | Bioteknik |
| Sälj | 0 | Betyg |
|
| Håll | 0 | Konsensus |
|
| Köp | 1 |
Loading...
Kontaktinformation:Land: Nederländerna
Branschöversikt Sequana Medical
Loading...
| År | Omsättning | Totala sektorer | marknadsandel |
|---|---|---|---|
| 2019 | 1 | 136,070 | 0.00 % |
| 2020 | 1 | 153,065 | 0.00 % |
| 2021 | 0 | 227,669 | 0.00 % |
| 2022 | 1 | 260,393 | 0.00 % |
| 2023 | 1 | 215,054 | 0.00 % |
Råd Sequana Medical
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| 27 maj 2025 | KBC Securities | Sequana Medical | Köp | 5.00 | 78.00 % |
| 21 november 2024 | KBC Securities | Sequana Medical | Köp | 6.00 | 81.67 % |
| 22 mars 2024 | KBC Securities | Sequana Medical | Köp | 6.00 | 75.00 % |
| 30 januari 2024 | KBC Securities | Sequana Medical | Köp | 7.00 | 62.43 % |
| 19 oktober 2023 | KBC Securities | Sequana Medical | Köp | 7.00 | 87.86 % |
| 2 maj 2023 | KBC Securities | Sequana Medical | Köp | 7.00 | 79.57 % |
| 2 maj 2023 | DeGroof Petercam | Sequana Medical | Köp | 10.00 | 85.80 % |
Nyheter Sequana Medical
No Records Found
Årsredovisningar Sequana Medical
No records found
Profil Sequana Medical
No Records Found
Results Sequana Medical
| Resultat |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Intäkter |
2
|
1
|
1
|
1
|
1
|
1
|
| Kostnader |
13
|
15
|
10
|
15
|
16
|
20
|
| Vinst |
-12
|
-14
|
-8
|
-14
|
-15
|
-19
|
| Vinstmarginal |
-688.10
|
-937.58
|
-633.08
|
-1357.28
|
-1544.33
|
-1990.62
|
| Avkastning på investering |
4128.57
|
209.45
|
178.52
|
74.52
|
-1610.75
|
-17372.73
|
Balans Sequana Medical
| Balans |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Eget kapital |
0
|
-7
|
-5
|
-19
|
1
|
|
| Skuld |
5
|
10
|
8
|
22
|
8
|
14
|
| Balansomslutning |
5
|
4
|
4
|
3
|
9
|
14
|
| Betalningsförmåga |
-5.98
|
-175.07
|
-130.97
|
-561.68
|
9.95
|
0.77
|
| Kontantbelopp |
1
|
1
|
2
|
1
|
6
|
11
|
| Kassaflöde |
-11
|
-13
|
-8
|
-10
|
-18
|
-17
|
| Anställda |
0
|
0
|
0
|
0
|
0
|
|
| Intäkter per anställd |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Kassaflöde / skulder |
-2.27
|
-1.22
|
-1.03
|
-0.45
|
-2.19
|
-1.21
|
Details Sequana Medical
| Detaljer |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Pris |
0.0
|
0.0
|
0.0
|
6.26
|
11.80
|
| Resultat per aktie |
-1.11
|
-0.65
|
-1.11
|
-1.22
|
-1.25
|
| Koers / winst-verhouding |
0.0
|
0.0
|
0.0
|
-5.13
|
-0.88
|
| Utdelning |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Utdelnings % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Utbetalnings% |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Bokfört värde |
-0.53
|
-0.37
|
-1.49
|
0.07
|
0.01
|
| Marknad att boka |
0.0
|
0.0
|
0.0
|
0.01
|
0.01
|
| Kontanter per aktie |
-1.01
|
-0.66
|
-0.78
|
-1.47
|
-1.08
|
| Aktier |
13
|
13
|
13
|
13
|
16
|
| Börsvärde |
0,00
|
0,00
|
0,00
|
78,95
|
17,36
|
Utdelning Sequana Medical
Price Info Sequana Medical
|
Datum
|
Pris
|
|---|---|
|
15 aug 2025
|
1.10
|
|
08 aug 2025
|
1.23
|
|
07 aug 2025
|
1.36
|
|
06 aug 2025
|
1.45
|
|
05 aug 2025
|
1.49
|
|
04 aug 2025
|
1.40
|
|
01 aug 2025
|
1.38
|
|
31 jul 2025
|
1.36
|
|
30 jul 2025
|
1.39
|
|
29 jul 2025
|
1.37
|
|
28 jul 2025
|
1.41
|
|
25 jul 2025
|
1.34
|
|
24 jul 2025
|
1.40
|
|
23 jul 2025
|
1.35
|
|
22 jul 2025
|
1.29
|
|
21 jul 2025
|
1.34
|
|
18 jul 2025
|
1.24
|
|
17 jul 2025
|
1.27
|
|
16 jul 2025
|
1.27
|
|
15 jul 2025
|
1.30
|
|
14 jul 2025
|
1.31
|
|
11 jul 2025
|
1.31
|
|
10 jul 2025
|
1.36
|
|
09 jul 2025
|
1.31
|
|
08 jul 2025
|
1.34
|
|
07 jul 2025
|
1.39
|
|
04 jul 2025
|
1.53
|
|
03 jul 2025
|
1.41
|
|
02 jul 2025
|
1.40
|
|
01 jul 2025
|
1.53
|
| Om oss | Nätverk | Samarbetspartners |
| Fpgroup.nlRSS feedinfo@analist.nl | Analist.nlLinksISINGlossary |
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 Scanaktier. Alla rättigheter reserverade
Developed and maintained by 